Cocquyt V - Search Results

1

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis.

Cocquyt V, Van Belle S, Reinhardt RR, Decramer ML, O'Brien M, Schellens JH, Borms M, Verbeke L, Van Aelst F, De Smet M, Carides AD, Eldridge K, Gertz BJ. Cocquyt V, et al. Eur J Cancer. 2001 May;37(7):835-42. doi: 10.1016/s0959-8049(00)00416-0. Eur J Cancer. 2001. PMID: 11313170 Clinical Trial.

2

Fosaprepitant dimeglumine (MK-0517 or L-785,298), an intravenous neurokinin-1 antagonist for the prevention of chemotherapy induced nausea and vomiting.

Van Belle SJ, Cocquyt V. Van Belle SJ, et al. Among authors: cocquyt v. Expert Opin Pharmacother. 2008 Dec;9(18):3261-70. doi: 10.1517/14656560802548463. Expert Opin Pharmacother. 2008. PMID: 19040346 Review.

3

Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy.

Van Belle SJ, Cocquyt V. Van Belle SJ, et al. Among authors: cocquyt v. Crit Rev Oncol Hematol. 2003 Jul;47(1):1-11. doi: 10.1016/s1040-8428(03)00093-3. Crit Rev Oncol Hematol. 2003. PMID: 12853095 Review.

4

Pharmacokinetics of intravenous alendronate.

Cocquyt V, Kline WF, Gertz BJ, Van Belle SJ, Holland SD, DeSmet M, Quan H, Vyas KP, Zhang KE, De Grève J, Porras AG. Cocquyt V, et al. J Clin Pharmacol. 1999 Apr;39(4):385-93. doi: 10.1177/00912709922007958. J Clin Pharmacol. 1999. PMID: 10197297 Clinical Trial.

5

Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group.

Van Belle SJ, Cocquyt VF, Bleiberg H, Canon JL, Buyse M, Hulstaert F, De Witte M, De Keyser P, Westelinck K. Van Belle SJ, et al. Among authors: cocquyt vf. Anticancer Drugs. 1995 Feb;6 Suppl 1:22-30. Anticancer Drugs. 1995. PMID: 7749166 Clinical Trial.

6

Dose-finding study of tropisetron in cisplatin-induced nausea and vomiting.

Van Belle SJ, Stamatakis L, Bleiberg H, Cocquyt VF, Michel J, de Bruijn KM. Van Belle SJ, et al. Among authors: cocquyt vf. Ann Oncol. 1994 Nov;5(9):821-5. doi: 10.1093/oxfordjournals.annonc.a059011. Ann Oncol. 1994. PMID: 7848884 Free article. Clinical Trial.

7

Lobular carcinoma in situ and invasive lobular cancer of the breast.

Cocquyt V, Van Belle S. Cocquyt V, et al. Curr Opin Obstet Gynecol. 2005 Feb;17(1):55-60. doi: 10.1097/00001703-200502000-00010. Curr Opin Obstet Gynecol. 2005. PMID: 15711412 Review.

8

Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients.

Nygren P, Hande K, Petty KJ, Fedgchin M, van Dyck K, Majumdar A, Panebianco D, de Smet M, Ahmed T, Murphy MG, Gottesdiener KM, Cocquyt V, van Belle S. Nygren P, et al. Among authors: cocquyt v. Cancer Chemother Pharmacol. 2005 Jun;55(6):609-16. doi: 10.1007/s00280-004-0946-3. Epub 2005 Feb 19. Cancer Chemother Pharmacol. 2005. PMID: 15723220 Clinical Trial.

9

Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma.

Van Gele M, Leonard JH, Van Roy N, Van Limbergen H, Van Belle S, Cocquyt V, Salwen H, De Paepe A, Speleman F. Van Gele M, et al. Among authors: cocquyt v. Int J Cancer. 2002 Sep 10;101(2):137-45. doi: 10.1002/ijc.10591. Int J Cancer. 2002. PMID: 12209990 Review.

10

Abdominal pain with anorexia in patients with breast carcinoma.

Van Trappen P, Serreyn R, Elewaut AE, Cocquyt V, Van Belle S. Van Trappen P, et al. Among authors: cocquyt v. Ann Oncol. 1998 Nov;9(11):1243-5. doi: 10.1023/a:1008287007819. Ann Oncol. 1998. PMID: 9862056 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters